Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma, Angiex Enter Clinical Readiness Pact | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

MilliporeSigma, Angiex Enter Clinical Readiness Pact

MilliporeSigma to provide access to process development tools, education programs and training

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has entered a collaboration with Angiex, Inc. to support the development of Angiex’s lead oncology antibody drug candidate for clinical use. Angiex is developing TM4SF1 as a potential therapy for cancer against a vascular target. 

This collaboration is the first project to be undertaken at MilliporeSigma’s new biodevelopment center in Burlington, MA, which will open in October 2017. MilliporeSigma will provide access to process development tools, education programs and training.

“Companies benefit from our expertise and experience in developing GMP manufacturing processes for early clinical development programs,” said Udit Batra, chief executive officer, MilliporeSigma. “With an end-to-end approach, MilliporeSigma can facilitate and accelerate scaling and technical transfer for companies like Angiex.”

Angiex chief executive officer, Dr. Paul Jaminet, said, “Through this collaboration, Angiex hopes to accelerate our path to the clinic. We appreciate MilliporeSigma’s expertise in bringing to cancer patients an innovative treatment capable of addressing the most dangerous solid tumors.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics